Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.

<strong>Fundament: </strong>The great advances of modern medicine in the last 30 years, have deepened on the treatment of acute myocardial infarct dynamically and efficiently, allowing at present to show good results not only in the decrease of the mortality rate but also in the improvem...

Full description

Bibliographic Details
Main Authors: René Tomás Manso Fernández, Francisco Valladares Carvajal, Claudio González Rodríguez., Marcos D. Iraola Ferrer
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2005-04-01
Series:Medisur
Subjects:
Online Access:http://www.medisur.sld.cu/index.php/medisur/article/view/87
_version_ 1811209869951238144
author René Tomás Manso Fernández
Francisco Valladares Carvajal
Claudio González Rodríguez.
Marcos D. Iraola Ferrer
author_facet René Tomás Manso Fernández
Francisco Valladares Carvajal
Claudio González Rodríguez.
Marcos D. Iraola Ferrer
author_sort René Tomás Manso Fernández
collection DOAJ
description <strong>Fundament: </strong>The great advances of modern medicine in the last 30 years, have deepened on the treatment of acute myocardial infarct dynamically and efficiently, allowing at present to show good results not only in the decrease of the mortality rate but also in the improvement of the patientâ?Ts quality of life. <strong>Objective</strong>: To offer the precise results with recombinant sterptokinase in elder and non-elder patients with an acute myocardial infarct. <strong>Method</strong>: prospective observational study of 325 patients admitted with a diagnosis of an acute myocardial infarct at the ¨Dr. Gustavo Aldereguia Lima¨ Hospital. These patients received thrombolitic treatment with recombinant strptokinase (Heberkinase) i a dose of 1 500 000 units, and treatment with 325 mg of acetil salicilic acid too. <strong>Results</strong>: The presence of the infarct was more frequent in males (68,31%) mainly associated to the smoking habit, Hypertension, and cholesterolemia in patients less than 74 years of age and in those patients aged 75 or more, the infarct was associated to Hypertension and Diabetes. The most affected side of the heart was the anterior part(44,6%), and the thrombolitic treatment was developd in an average of 211, 76 minutes. Deaths increased with age. The most significant variables associated to mortality in the infarcted patients were the fact of being hemodinamically classified into a Killip-Kimball (K-K) Grade III-IV and having had arrhythmia and cardiac rupture.<span style="font-family: Calibri;"><strong></strong></span>
first_indexed 2024-04-12T04:46:15Z
format Article
id doaj.art-e95e010d328a43fd82fbd96b1e8390fc
institution Directory Open Access Journal
issn 1727-897X
language Spanish
last_indexed 2024-04-12T04:46:15Z
publishDate 2005-04-01
publisher Centro Provincial de Información de Ciencias Médicas. Cienfuegos
record_format Article
series Medisur
spelling doaj.art-e95e010d328a43fd82fbd96b1e8390fc2022-12-22T03:47:29ZspaCentro Provincial de Información de Ciencias Médicas. CienfuegosMedisur1727-897X2005-04-0131465087Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.René Tomás Manso FernándezFrancisco Valladares CarvajalClaudio González Rodríguez.Marcos D. Iraola Ferrer<strong>Fundament: </strong>The great advances of modern medicine in the last 30 years, have deepened on the treatment of acute myocardial infarct dynamically and efficiently, allowing at present to show good results not only in the decrease of the mortality rate but also in the improvement of the patientâ?Ts quality of life. <strong>Objective</strong>: To offer the precise results with recombinant sterptokinase in elder and non-elder patients with an acute myocardial infarct. <strong>Method</strong>: prospective observational study of 325 patients admitted with a diagnosis of an acute myocardial infarct at the ¨Dr. Gustavo Aldereguia Lima¨ Hospital. These patients received thrombolitic treatment with recombinant strptokinase (Heberkinase) i a dose of 1 500 000 units, and treatment with 325 mg of acetil salicilic acid too. <strong>Results</strong>: The presence of the infarct was more frequent in males (68,31%) mainly associated to the smoking habit, Hypertension, and cholesterolemia in patients less than 74 years of age and in those patients aged 75 or more, the infarct was associated to Hypertension and Diabetes. The most affected side of the heart was the anterior part(44,6%), and the thrombolitic treatment was developd in an average of 211, 76 minutes. Deaths increased with age. The most significant variables associated to mortality in the infarcted patients were the fact of being hemodinamically classified into a Killip-Kimball (K-K) Grade III-IV and having had arrhythmia and cardiac rupture.<span style="font-family: Calibri;"><strong></strong></span>http://www.medisur.sld.cu/index.php/medisur/article/view/87terapia trombolíticainfarto del miocardio
spellingShingle René Tomás Manso Fernández
Francisco Valladares Carvajal
Claudio González Rodríguez.
Marcos D. Iraola Ferrer
Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.
Medisur
terapia trombolítica
infarto del miocardio
title Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.
title_full Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.
title_fullStr Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.
title_full_unstemmed Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.
title_short Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients.
title_sort results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients
topic terapia trombolítica
infarto del miocardio
url http://www.medisur.sld.cu/index.php/medisur/article/view/87
work_keys_str_mv AT renetomasmansofernandez resultsofthrombolytictreatmentwithrecombinantstreptokinaseinelderlyandnonelderlypatients
AT franciscovalladarescarvajal resultsofthrombolytictreatmentwithrecombinantstreptokinaseinelderlyandnonelderlypatients
AT claudiogonzalezrodriguez resultsofthrombolytictreatmentwithrecombinantstreptokinaseinelderlyandnonelderlypatients
AT marcosdiraolaferrer resultsofthrombolytictreatmentwithrecombinantstreptokinaseinelderlyandnonelderlypatients